Shares of Biogen Inc. BIIB rallied 2.60% to $140.64 Friday, on what proved to be an all-around grim trading session for the ...

The global Gene Therapy market, valued at US$7.21 billion in 2023, is forecasted to grow at a robust CAGR of 19.4%, reaching ...

The global Gene Therapy market, valued at US$7.21 billion in 2023, is forecasted to grow at a robust CAGR of 19.4%, reaching US$8.85 billion ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Irhythm Technologies (IRTC – Research Report), Vir ...

In this article, we are going to take a look at where Biogen Inc. (NASDAQ ... and advanced data and analytics via sales of innovative technologies (such as generative AI) to providers and payers.

Since its founding in 1993, the company has been a trailblazer in visual computing – from reinventing computer graphics to adopting groundbreaking technologies like ray tracing and AI acceleration.

10 luxury brand logos have mastered it. They've become more than marks on products—they're cultural touchstones, over decades and continents. Logos are stories we tell ourselves. The best ones?

Investors in Biogen Inc (Symbol: BIIB) saw new options begin trading today, for the March 2026 expiration. One of the key data points that goes into the price an option buyer is willing to pay ...

The collision of AI advancement and post-pandemic work policies has created an urgent inflection point for how we build and maintain workplace connections. As major companies wrestle with return ...